Compare CLDX & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | TRUP |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2008 | 2014 |
| Metric | CLDX | TRUP |
|---|---|---|
| Price | $25.87 | $34.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $44.10 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 738.8K | 346.1K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | $2,599,000.00 | ★ $1,399,759,000.00 |
| Revenue This Year | N/A | $14.10 |
| Revenue Next Year | $23.23 | $9.54 |
| P/E Ratio | ★ N/A | $97.81 |
| Revenue Growth | N/A | ★ 12.50 |
| 52 Week Low | $14.40 | $31.00 |
| 52 Week High | $30.50 | $57.89 |
| Indicator | CLDX | TRUP |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 36.33 |
| Support Level | $25.15 | $35.39 |
| Resistance Level | $28.00 | $36.96 |
| Average True Range (ATR) | 1.16 | 1.18 |
| MACD | -0.09 | -0.19 |
| Stochastic Oscillator | 28.96 | 8.35 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.